Application | Comment | Organism |
---|---|---|
medicine | potential target for the development of antituberculosis agents | Mycobacterium tuberculosis |
Cloned (Comment) | Organism |
---|---|
expressed in Escherichia coli | Mycobacterium tuberculosis |
Crystallization (Comment) | Organism |
---|---|
hanging drop vapour diffusion method using 0.1 M Tris-HCl, pH range 8.2-8.7, 0.2 M MgCl2, and 30% polyethylene glycol 4000 | Mycobacterium tuberculosis |
Protein Variants | Comment | Organism |
---|---|---|
C161A | catalytically impaired mutant, tested in an assay using the nonphysiological electron donor methyl viologen and sulfite as substrate | Mycobacterium tuberculosis |
C161S | catalytically impaired mutant, tested in an assay using the nonphysiological electron donor methyl viologen and sulfite as substrate | Mycobacterium tuberculosis |
Y69A | catalytically impaired mutant, tested in an assay using the nonphysiological electron donor methyl viologen and sulfite as substrate | Mycobacterium tuberculosis |
Y69F | catalytically impaired mutant, tested in an assay using the nonphysiological electron donor methyl viologen and sulfite as substrate | Mycobacterium tuberculosis |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
[4Fe-4S] center | - |
Mycobacterium tuberculosis |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mycobacterium tuberculosis | P9WJ03 | - |
- |
Mycobacterium tuberculosis H37Rv | P9WJ03 | - |
- |
Purification (Comment) | Organism |
---|---|
Ni2+-nitrilotriacetic acid affinity matrix and Q-Sepharose column chromatography | Mycobacterium tuberculosis |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
additional information | - |
the enzyme has a specific activity of 2.0 units/mg protein | Mycobacterium tuberculosis |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | NirA has a pronounced preference for sulfite over nitrite as substrate | Mycobacterium tuberculosis | ? | - |
? | |
additional information | NirA has a pronounced preference for sulfite over nitrite as substrate | Mycobacterium tuberculosis H37Rv | ? | - |
? | |
sulfite + methyl viologen | - |
Mycobacterium tuberculosis | sulfide + ? | - |
? | |
sulfite + methyl viologen | - |
Mycobacterium tuberculosis H37Rv | sulfide + ? | - |
? |
Subunits | Comment | Organism |
---|---|---|
monomer | x-ray crystallography | Mycobacterium tuberculosis |
Synonyms | Comment | Organism |
---|---|---|
ferredoxin-dependent sulfite reductase | - |
Mycobacterium tuberculosis |
NirA | - |
Mycobacterium tuberculosis |
siroheme- and [Fe4-S4]-dependent NirA | - |
Mycobacterium tuberculosis |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
siroheme | - |
Mycobacterium tuberculosis |